Status:
ACTIVE_NOT_RECRUITING
The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Prostate Cancer
Eligibility:
MALE
18-80 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine if there is a difference in intra-abdominal pressure which surgeons use during surgery and post-surgery pain in men who undergo robotic prostate surgery with ...
Eligibility Criteria
Inclusion
- Adult patients under the age of 80
- American Society of Anesthesiologists Physical Status 1, 2, 3.
- Elective Robotic Prostatectomy
- Patient undergoing surgery at Josie Robertson Surgical Center
Exclusion
- Age younger than 18
- Inability to provide informed consent
- Allergy to rocuronium, sugammadex, midazolam, propofol, fentanyl, lidocaine, mannitol (IV Acetaeminophen), IV Acetaminophen, Ketorolac, Morphine, Hydromorphone, Dexamethasone, Zofran, Benadryl, Compazine
- Neuromuscular disease
- Any patient with previous abdominal surgery less than or equal to 20 years prior to scheduled surgery date
- Patients with BMI\>35
- Severe renal impairment (Creatinine clearance \< 30 ml/min)
- Patient receiving Toremifene or any history of receiving Toremifene
- Chronic pain patients
- Patients receiving suboxone
- Patients receiving succinylcholine
Key Trial Info
Start Date :
January 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2026
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT03808077
Start Date
January 14 2019
End Date
January 1 2026
Last Update
June 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065